Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma
2004 ◽
Vol 10
(8)
◽
pp. 1146
◽
Ming Shi
◽
Bing Zhang
◽
Zi-Rong Tang
◽
Zhou-Yun Lei
◽
Hui-Fen Wang
◽
...
2017 ◽
Vol 66
(1)
◽
pp. S632
Y.-B. Xie
◽
J.-Y. Zhang
◽
M. Shi
◽
F.-S. Wang
2015 ◽
Vol 6
(38)
◽
pp. 41339-41349
◽
Shan-Shan Jiang
◽
Yan Tang
◽
Yao-Jun Zhang
◽
De-Sheng Weng
◽
Zhong-Guo Zhou
◽
...
2016 ◽
Vol 11
(3)
◽
pp. 1885-1888
◽
RUNMEI LI
◽
FANG YAN
◽
LIANG LIU
◽
HUI LI
◽
BAOZHU REN
◽
...
2015 ◽
Vol 26
◽
pp. ix103
◽
2016 ◽
Vol 39
(3)
◽
pp. 140-148
◽
Hyeon-Seok Eom
◽
Beom K. Choi
◽
Youngjoo Lee
◽
Hyewon Lee
◽
Tak Yun
◽
...
Yao Gao
◽
Jia Guo
◽
Xuli Bao
◽
Fang Xiong
◽
Yanpin Ma
◽
...
2004 ◽
Vol 19
(5)
◽
pp. 589-600
Shaoliang Chen
◽
Beilei Li
◽
Hong Xie
◽
Li Xu
◽
Guangjun Niu
◽
...
2008 ◽
Vol 72
(1)
◽
pp. S128-S129
◽
H. Cardenes
◽
T. Price
◽
S. Perkins
◽
M. Maluccio
◽
P. Kwo
◽
...
2004 ◽
Vol 19
(5)
◽
pp. 589-600
◽
Shaoliang Chen
◽
Beilei Li
◽
Hong Xie
◽
Li Xu
◽
Guangjun Niu
◽
...
2005 ◽
Vol 23
(16_suppl)
◽
pp. 4124-4124
◽
H. Kato
◽
S. Yamada
◽
S. Yasuda
◽
K. Yamaguchi
◽
H. Kitabayashi
◽
...